Copyright
©The Author(s) 2024.
World J Hepatol. Nov 27, 2024; 16(11): 1331-1338
Published online Nov 27, 2024. doi: 10.4254/wjh.v16.i11.1331
Published online Nov 27, 2024. doi: 10.4254/wjh.v16.i11.1331
Figure 1 PRISMA flowchart detailing study selection.
Figure 2 Forest plot showing the association between the urine neutrophil gelatinase-associated lipocalin biomarker and acute tubular necrosis in hospitalized patients with cirrhosis.
OR: Odds ratio; lcl: Lower confidence limit; ucl: Upper confidence limit; prob: Probability.
Figure 3 Funnel plot demonstrating the publication bias among the included studies.
Figure 4 Forest plots demonstrating the neutrophil gelatinase-associated lipocalin predictiveness and mortality in decompensated cirrhosis patient with acute kidney injury.
A: Forest plot showing the area under the curve for urine neutrophil gelatinase-associated lipocalin predictiveness of acute kidney injury in decompensated cirrhosis patients. The pooled estimate demonstrates the cumulative result of all the studies combined; B: Forest plot of the meta-analysis of mortality among decompensated cirrhosis patients with acute kidney injury across different studies. The lower diamond in the graph demonstrates the cumulative result of all the studies combined.
- Citation: Agrawal N, Louis-Jean S, Ladiwala Z, Adnani H, Kamal A, Karpman M, Fleisher AS, Singh S. Reliability of neutrophil gelatinase-associated lipocalin in detecting acute tubular necrosis in decompensated cirrhosis: Systematic review and meta-analysis. World J Hepatol 2024; 16(11): 1331-1338
- URL: https://www.wjgnet.com/1948-5182/full/v16/i11/1331.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i11.1331